Literature DB >> 6274969

Virus-specific IgG and IgM antibodies in normal and immunocompromised subjects infected with cytomegalovirus.

L Rasmussen, D Kelsall, R Nelson, W Carney, M Hirsch, D Winston, J Preiksaitis, T C Merigan.   

Abstract

Levels of IgG and IgM antibodies t human cytomegalovirus (CMV) were measured using a solid-phase radioimmunoassay. Individuals positive by complement-fixation test consistently had detectable IgG titers by radioimmunoassay, but no quantitative relationship was apparent. An elevated IgM titer was considered specific for CMV infection because sera from individuals with other herpesvirus infections did not cross-react. In patients with mononucleosis, elevated titers of IgM antibody to CMV correlated (P less than 0.001) with active infection and were highest during viremia. Titers of IgG antibody to CMV during and after symptomatic infection were similar to those of asymptomatic positive individuals. Increases in CMV-specific IGM were observed in both primary and reactivated infections in cardiac transplant recipients. In a small group of cardiac transplant recipients with recurrent symptomatic disease, IgM titers were low at the time of viruria and did not increase with CMV tissue involvement, a result which suggests that quantitative deficiencies in IgM may be related to the severity of CMV infections.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6274969     DOI: 10.1093/infdis/145.2.191

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  38 in total

1.  Identification of cell surface receptors for the 86-kilodalton glycoprotein of human cytomegalovirus.

Authors:  S Keay; T C Merigan; L Rasmussen
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

2.  Antibodies against the gH/gL/UL128/UL130/UL131 complex comprise the majority of the anti-cytomegalovirus (anti-CMV) neutralizing antibody response in CMV hyperimmune globulin.

Authors:  Ashley E Fouts; Pamela Chan; Jean-Philippe Stephan; Richard Vandlen; Becket Feierbach
Journal:  J Virol       Date:  2012-04-24       Impact factor: 5.103

3.  Quantitative measurement of cytomegalovirus-specific IgG and IgM antibodies in relation to cytomegalovirus antigenaemia and disease activity in kidney recipients with an active cytomegalovirus infection.

Authors:  M Van der Giessen; A P van den Berg; W van der Bij; S Postma; W J van Son; T H The
Journal:  Clin Exp Immunol       Date:  1990-04       Impact factor: 4.330

4.  Antibody response to individual cytomegalovirus structural proteins in different groups of subjects.

Authors:  G Mirolo; B Baldassarri; A Ripalti; M C Re; M Clementi; A Manzin; M P Landini
Journal:  Eur J Clin Microbiol       Date:  1987-04       Impact factor: 3.267

5.  Evaluation of Abbott CMV-M enzyme immunoassay for detection of cytomegalovirus immunoglobulin M antibody.

Authors:  L Schaefer; A Cesario; G Demmler; S Plotkin; S Stagno; C Elrod; J Ringler; N Tustin
Journal:  J Clin Microbiol       Date:  1988-10       Impact factor: 5.948

6.  Synthesis and processing of the envelope gp55-116 complex of human cytomegalovirus.

Authors:  W J Britt; D Auger
Journal:  J Virol       Date:  1986-04       Impact factor: 5.103

7.  Influence of immunosuppressive therapy with azathioprine and prednisolone on serum-immunoglobulin concentration in renal transplanted patients.

Authors:  R H Dennin; E Schulz; K Sack; K Dalhoff; J Hoyer
Journal:  Klin Wochenschr       Date:  1985-11-04

8.  Cytomegalovirus infection in gastrointestinal tracts of patients infected with HIV-1 or AIDS.

Authors:  N D Francis; A W Boylston; A H Roberts; J M Parkin; A J Pinching
Journal:  J Clin Pathol       Date:  1989-10       Impact factor: 3.411

9.  Antibody response to recombinant lambda gt11 fusion proteins in cytomegalovirus infection.

Authors:  M P Landini; T Lazzarotto; A Ripalti; M X Guan; M La Placa
Journal:  J Clin Microbiol       Date:  1989-10       Impact factor: 5.948

10.  Alpha-interferon administration in cytomegalovirus retinitis.

Authors:  S W Chou; J S Dylewski; M W Gaynon; P R Egbert; T C Merigan
Journal:  Antimicrob Agents Chemother       Date:  1984-01       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.